Global Allergy Immunotherapy Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Allergy Immunotherapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.
LP Information, Inc. (LPI) ' newest research report, the “Allergy Immunotherapy Industry Forecast” looks at past sales and reviews total world Allergy Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Allergy Immunotherapy sales for 2025 through 2031. With Allergy Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allergy Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Allergy Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Allergy Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allergy Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allergy Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allergy Immunotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Immunotherapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Allergy Immunotherapy market?
What factors are driving Allergy Immunotherapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Allergy Immunotherapy market opportunities vary by end market size?
How does Allergy Immunotherapy break out by Type, by Application?
The global Allergy Immunotherapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.
LP Information, Inc. (LPI) ' newest research report, the “Allergy Immunotherapy Industry Forecast” looks at past sales and reviews total world Allergy Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Allergy Immunotherapy sales for 2025 through 2031. With Allergy Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allergy Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Allergy Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Allergy Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allergy Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allergy Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allergy Immunotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Immunotherapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- Allergic Rhinitis
- Allergic Asthma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- HAL
- Holister Stier
- Leti
What is the 10-year outlook for the global Allergy Immunotherapy market?
What factors are driving Allergy Immunotherapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Allergy Immunotherapy market opportunities vary by end market size?
How does Allergy Immunotherapy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Allergy Immunotherapy Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Allergy Immunotherapy by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Allergy Immunotherapy by Country/Region, 2020, 2024 & 2031
2.2 Allergy Immunotherapy Segment by Type
2.2.1 Subcutaneous Immunotherapy
2.2.2 Sublingual Immunotherapy
2.3 Allergy Immunotherapy Sales by Type
2.3.1 Global Allergy Immunotherapy Sales Market Share by Type (2020-2025)
2.3.2 Global Allergy Immunotherapy Revenue and Market Share by Type (2020-2025)
2.3.3 Global Allergy Immunotherapy Sale Price by Type (2020-2025)
2.4 Allergy Immunotherapy Segment by Application
2.4.1 Allergic Rhinitis
2.4.2 Allergic Asthma
2.4.3 Others
2.5 Allergy Immunotherapy Sales by Application
2.5.1 Global Allergy Immunotherapy Sale Market Share by Application (2020-2025)
2.5.2 Global Allergy Immunotherapy Revenue and Market Share by Application (2020-2025)
2.5.3 Global Allergy Immunotherapy Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Allergy Immunotherapy Breakdown Data by Company
3.1.1 Global Allergy Immunotherapy Annual Sales by Company (2020-2025)
3.1.2 Global Allergy Immunotherapy Sales Market Share by Company (2020-2025)
3.2 Global Allergy Immunotherapy Annual Revenue by Company (2020-2025)
3.2.1 Global Allergy Immunotherapy Revenue by Company (2020-2025)
3.2.2 Global Allergy Immunotherapy Revenue Market Share by Company (2020-2025)
3.3 Global Allergy Immunotherapy Sale Price by Company
3.4 Key Manufacturers Allergy Immunotherapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Allergy Immunotherapy Product Location Distribution
3.4.2 Players Allergy Immunotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALLERGY IMMUNOTHERAPY BY GEOGRAPHIC REGION
4.1 World Historic Allergy Immunotherapy Market Size by Geographic Region (2020-2025)
4.1.1 Global Allergy Immunotherapy Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Allergy Immunotherapy Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Allergy Immunotherapy Market Size by Country/Region (2020-2025)
4.2.1 Global Allergy Immunotherapy Annual Sales by Country/Region (2020-2025)
4.2.2 Global Allergy Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Allergy Immunotherapy Sales Growth
4.4 APAC Allergy Immunotherapy Sales Growth
4.5 Europe Allergy Immunotherapy Sales Growth
4.6 Middle East & Africa Allergy Immunotherapy Sales Growth
5 AMERICAS
5.1 Americas Allergy Immunotherapy Sales by Country
5.1.1 Americas Allergy Immunotherapy Sales by Country (2020-2025)
5.1.2 Americas Allergy Immunotherapy Revenue by Country (2020-2025)
5.2 Americas Allergy Immunotherapy Sales by Type (2020-2025)
5.3 Americas Allergy Immunotherapy Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Allergy Immunotherapy Sales by Region
6.1.1 APAC Allergy Immunotherapy Sales by Region (2020-2025)
6.1.2 APAC Allergy Immunotherapy Revenue by Region (2020-2025)
6.2 APAC Allergy Immunotherapy Sales by Type (2020-2025)
6.3 APAC Allergy Immunotherapy Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Allergy Immunotherapy by Country
7.1.1 Europe Allergy Immunotherapy Sales by Country (2020-2025)
7.1.2 Europe Allergy Immunotherapy Revenue by Country (2020-2025)
7.2 Europe Allergy Immunotherapy Sales by Type (2020-2025)
7.3 Europe Allergy Immunotherapy Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Allergy Immunotherapy by Country
8.1.1 Middle East & Africa Allergy Immunotherapy Sales by Country (2020-2025)
8.1.2 Middle East & Africa Allergy Immunotherapy Revenue by Country (2020-2025)
8.2 Middle East & Africa Allergy Immunotherapy Sales by Type (2020-2025)
8.3 Middle East & Africa Allergy Immunotherapy Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Allergy Immunotherapy
10.3 Manufacturing Process Analysis of Allergy Immunotherapy
10.4 Industry Chain Structure of Allergy Immunotherapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Allergy Immunotherapy Distributors
11.3 Allergy Immunotherapy Customer
12 WORLD FORECAST REVIEW FOR ALLERGY IMMUNOTHERAPY BY GEOGRAPHIC REGION
12.1 Global Allergy Immunotherapy Market Size Forecast by Region
12.1.1 Global Allergy Immunotherapy Forecast by Region (2026-2031)
12.1.2 Global Allergy Immunotherapy Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Allergy Immunotherapy Forecast by Type (2026-2031)
12.7 Global Allergy Immunotherapy Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 ALK-Abello
13.1.1 ALK-Abello Company Information
13.1.2 ALK-Abello Allergy Immunotherapy Product Portfolios and Specifications
13.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ALK-Abello Main Business Overview
13.1.5 ALK-Abello Latest Developments
13.2 Stallergenes Greer
13.2.1 Stallergenes Greer Company Information
13.2.2 Stallergenes Greer Allergy Immunotherapy Product Portfolios and Specifications
13.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Stallergenes Greer Main Business Overview
13.2.5 Stallergenes Greer Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Allergy Immunotherapy Product Portfolios and Specifications
13.3.3 Merck Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Information
13.4.2 Allergy Therapeutics Allergy Immunotherapy Product Portfolios and Specifications
13.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Allergy Therapeutics Main Business Overview
13.4.5 Allergy Therapeutics Latest Developments
13.5 HAL
13.5.1 HAL Company Information
13.5.2 HAL Allergy Immunotherapy Product Portfolios and Specifications
13.5.3 HAL Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 HAL Main Business Overview
13.5.5 HAL Latest Developments
13.6 Holister Stier
13.6.1 Holister Stier Company Information
13.6.2 Holister Stier Allergy Immunotherapy Product Portfolios and Specifications
13.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Holister Stier Main Business Overview
13.6.5 Holister Stier Latest Developments
13.7 Leti
13.7.1 Leti Company Information
13.7.2 Leti Allergy Immunotherapy Product Portfolios and Specifications
13.7.3 Leti Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Leti Main Business Overview
13.7.5 Leti Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Allergy Immunotherapy Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Allergy Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subcutaneous Immunotherapy
Table 4. Major Players of Sublingual Immunotherapy
Table 5. Global Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 6. Global Allergy Immunotherapy Sales Market Share byType (2020-2025)
Table 7. Global Allergy Immunotherapy Revenue byType (2020-2025) & ($ million)
Table 8. Global Allergy Immunotherapy Revenue Market Share byType (2020-2025)
Table 9. Global Allergy Immunotherapy Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Allergy Immunotherapy Sale by Application (2020-2025) & (K Units)
Table 11. Global Allergy Immunotherapy Sale Market Share by Application (2020-2025)
Table 12. Global Allergy Immunotherapy Revenue by Application (2020-2025) & ($ million)
Table 13. Global Allergy Immunotherapy Revenue Market Share by Application (2020-2025)
Table 14. Global Allergy Immunotherapy Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Allergy Immunotherapy Sales by Company (2020-2025) & (K Units)
Table 16. Global Allergy Immunotherapy Sales Market Share by Company (2020-2025)
Table 17. Global Allergy Immunotherapy Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Allergy Immunotherapy Revenue Market Share by Company (2020-2025)
Table 19. Global Allergy Immunotherapy Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Allergy Immunotherapy Producing Area Distribution and Sales Area
Table 21. Players Allergy Immunotherapy Products Offered
Table 22. Allergy Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Allergy Immunotherapy Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Allergy Immunotherapy Sales Market Share Geographic Region (2020-2025)
Table 27. Global Allergy Immunotherapy Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Allergy Immunotherapy Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Allergy Immunotherapy Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Allergy Immunotherapy Sales Market Share by Country/Region (2020-2025)
Table 31. Global Allergy Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Allergy Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 34. Americas Allergy Immunotherapy Sales Market Share by Country (2020-2025)
Table 35. Americas Allergy Immunotherapy Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 37. Americas Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 38. APAC Allergy Immunotherapy Sales by Region (2020-2025) & (K Units)
Table 39. APAC Allergy Immunotherapy Sales Market Share by Region (2020-2025)
Table 40. APAC Allergy Immunotherapy Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 42. APAC Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 43. Europe Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 44. Europe Allergy Immunotherapy Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 46. Europe Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Allergy Immunotherapy Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Allergy Immunotherapy
Table 52. Key Market Challenges & Risks of Allergy Immunotherapy
Table 53. Key IndustryTrends of Allergy Immunotherapy
Table 54. Allergy Immunotherapy Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Allergy Immunotherapy Distributors List
Table 57. Allergy Immunotherapy Customer List
Table 58. Global Allergy Immunotherapy SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Allergy Immunotherapy RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Allergy Immunotherapy SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Allergy Immunotherapy Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Allergy Immunotherapy SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Allergy Immunotherapy Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Allergy Immunotherapy SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Allergy Immunotherapy RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Allergy Immunotherapy SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Allergy Immunotherapy RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Allergy Immunotherapy SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Allergy Immunotherapy RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Allergy Immunotherapy SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Allergy Immunotherapy RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ALK-Abello Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 73. ALK-Abello Allergy Immunotherapy Product Portfolios and Specifications
Table 74. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. ALK-Abello Main Business
Table 76. ALK-Abello Latest Developments
Table 77. Stallergenes Greer Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 78. Stallergenes Greer Allergy Immunotherapy Product Portfolios and Specifications
Table 79. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Stallergenes Greer Main Business
Table 81. Stallergenes Greer Latest Developments
Table 82. Merck Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Allergy Immunotherapy Product Portfolios and Specifications
Table 84. Merck Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. AllergyTherapeutics Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 88. AllergyTherapeutics Allergy Immunotherapy Product Portfolios and Specifications
Table 89. AllergyTherapeutics Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. AllergyTherapeutics Main Business
Table 91. AllergyTherapeutics Latest Developments
Table 92. HAL Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 93. HAL Allergy Immunotherapy Product Portfolios and Specifications
Table 94. HAL Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. HAL Main Business
Table 96. HAL Latest Developments
Table 97. Holister Stier Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Holister Stier Allergy Immunotherapy Product Portfolios and Specifications
Table 99. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Holister Stier Main Business
Table 101. Holister Stier Latest Developments
Table 102. Leti Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 103. Leti Allergy Immunotherapy Product Portfolios and Specifications
Table 104. Leti Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Leti Main Business
Table 106. Leti Latest Developments
LIST OFFIGURES
Figure 1. Picture of Allergy Immunotherapy
Figure 2. Allergy Immunotherapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Allergy Immunotherapy Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Allergy Immunotherapy Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Allergy Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Allergy Immunotherapy Sales Market Share by Country/Region (2024)
Figure 10. Allergy Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Subcutaneous Immunotherapy
Figure 12. Product Picture of Sublingual Immunotherapy
Figure 13. Global Allergy Immunotherapy Sales Market Share byType in 2025
Figure 14. Global Allergy Immunotherapy Revenue Market Share byType (2020-2025)
Figure 15. Allergy Immunotherapy Consumed in Allergic Rhinitis
Figure 16. Global Allergy Immunotherapy Market: Allergic Rhinitis (2020-2025) & (K Units)
Figure 17. Allergy Immunotherapy Consumed in Allergic Asthma
Figure 18. Global Allergy Immunotherapy Market: Allergic Asthma (2020-2025) & (K Units)
Figure 19. Allergy Immunotherapy Consumed in Others
Figure 20. Global Allergy Immunotherapy Market: Others (2020-2025) & (K Units)
Figure 21. Global Allergy Immunotherapy Sale Market Share by Application (2024)
Figure 22. Global Allergy Immunotherapy Revenue Market Share by Application in 2025
Figure 23. Allergy Immunotherapy Sales by Company in 2025 (K Units)
Figure 24. Global Allergy Immunotherapy Sales Market Share by Company in 2025
Figure 25. Allergy Immunotherapy Revenue by Company in 2025 ($ millions)
Figure 26. Global Allergy Immunotherapy Revenue Market Share by Company in 2025
Figure 27. Global Allergy Immunotherapy Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Allergy Immunotherapy Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 30. Americas Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 31. APAC Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 32. APAC Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 33. Europe Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 34. Europe Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 37. Americas Allergy Immunotherapy Sales Market Share by Country in 2025
Figure 38. Americas Allergy Immunotherapy Revenue Market Share by Country (2020-2025)
Figure 39. Americas Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 40. Americas Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 41. United States Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Allergy Immunotherapy Sales Market Share by Region in 2025
Figure 46. APAC Allergy Immunotherapy Revenue Market Share by Region (2020-2025)
Figure 47. APAC Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 48. APAC Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 49. China Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 53. India Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Allergy Immunotherapy Sales Market Share by Country in 2025
Figure 57. Europe Allergy Immunotherapy Revenue Market Share by Country (2020-2025)
Figure 58. Europe Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 59. Europe Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 60. Germany Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 61.France Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Allergy Immunotherapy Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 68. Egypt Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Allergy Immunotherapy in 2025
Figure 74. Manufacturing Process Analysis of Allergy Immunotherapy
Figure 75. Industry Chain Structure of Allergy Immunotherapy
Figure 76. Channels of Distribution
Figure 77. Global Allergy Immunotherapy Sales MarketForecast by Region (2026-2031)
Figure 78. Global Allergy Immunotherapy Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Allergy Immunotherapy Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Allergy Immunotherapy Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Allergy Immunotherapy Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Allergy Immunotherapy Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Allergy Immunotherapy Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Allergy Immunotherapy by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Allergy Immunotherapy by Country/Region, 2020, 2024 & 2031
2.2 Allergy Immunotherapy Segment by Type
2.2.1 Subcutaneous Immunotherapy
2.2.2 Sublingual Immunotherapy
2.3 Allergy Immunotherapy Sales by Type
2.3.1 Global Allergy Immunotherapy Sales Market Share by Type (2020-2025)
2.3.2 Global Allergy Immunotherapy Revenue and Market Share by Type (2020-2025)
2.3.3 Global Allergy Immunotherapy Sale Price by Type (2020-2025)
2.4 Allergy Immunotherapy Segment by Application
2.4.1 Allergic Rhinitis
2.4.2 Allergic Asthma
2.4.3 Others
2.5 Allergy Immunotherapy Sales by Application
2.5.1 Global Allergy Immunotherapy Sale Market Share by Application (2020-2025)
2.5.2 Global Allergy Immunotherapy Revenue and Market Share by Application (2020-2025)
2.5.3 Global Allergy Immunotherapy Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Allergy Immunotherapy Breakdown Data by Company
3.1.1 Global Allergy Immunotherapy Annual Sales by Company (2020-2025)
3.1.2 Global Allergy Immunotherapy Sales Market Share by Company (2020-2025)
3.2 Global Allergy Immunotherapy Annual Revenue by Company (2020-2025)
3.2.1 Global Allergy Immunotherapy Revenue by Company (2020-2025)
3.2.2 Global Allergy Immunotherapy Revenue Market Share by Company (2020-2025)
3.3 Global Allergy Immunotherapy Sale Price by Company
3.4 Key Manufacturers Allergy Immunotherapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Allergy Immunotherapy Product Location Distribution
3.4.2 Players Allergy Immunotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALLERGY IMMUNOTHERAPY BY GEOGRAPHIC REGION
4.1 World Historic Allergy Immunotherapy Market Size by Geographic Region (2020-2025)
4.1.1 Global Allergy Immunotherapy Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Allergy Immunotherapy Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Allergy Immunotherapy Market Size by Country/Region (2020-2025)
4.2.1 Global Allergy Immunotherapy Annual Sales by Country/Region (2020-2025)
4.2.2 Global Allergy Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Allergy Immunotherapy Sales Growth
4.4 APAC Allergy Immunotherapy Sales Growth
4.5 Europe Allergy Immunotherapy Sales Growth
4.6 Middle East & Africa Allergy Immunotherapy Sales Growth
5 AMERICAS
5.1 Americas Allergy Immunotherapy Sales by Country
5.1.1 Americas Allergy Immunotherapy Sales by Country (2020-2025)
5.1.2 Americas Allergy Immunotherapy Revenue by Country (2020-2025)
5.2 Americas Allergy Immunotherapy Sales by Type (2020-2025)
5.3 Americas Allergy Immunotherapy Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Allergy Immunotherapy Sales by Region
6.1.1 APAC Allergy Immunotherapy Sales by Region (2020-2025)
6.1.2 APAC Allergy Immunotherapy Revenue by Region (2020-2025)
6.2 APAC Allergy Immunotherapy Sales by Type (2020-2025)
6.3 APAC Allergy Immunotherapy Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Allergy Immunotherapy by Country
7.1.1 Europe Allergy Immunotherapy Sales by Country (2020-2025)
7.1.2 Europe Allergy Immunotherapy Revenue by Country (2020-2025)
7.2 Europe Allergy Immunotherapy Sales by Type (2020-2025)
7.3 Europe Allergy Immunotherapy Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Allergy Immunotherapy by Country
8.1.1 Middle East & Africa Allergy Immunotherapy Sales by Country (2020-2025)
8.1.2 Middle East & Africa Allergy Immunotherapy Revenue by Country (2020-2025)
8.2 Middle East & Africa Allergy Immunotherapy Sales by Type (2020-2025)
8.3 Middle East & Africa Allergy Immunotherapy Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Allergy Immunotherapy
10.3 Manufacturing Process Analysis of Allergy Immunotherapy
10.4 Industry Chain Structure of Allergy Immunotherapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Allergy Immunotherapy Distributors
11.3 Allergy Immunotherapy Customer
12 WORLD FORECAST REVIEW FOR ALLERGY IMMUNOTHERAPY BY GEOGRAPHIC REGION
12.1 Global Allergy Immunotherapy Market Size Forecast by Region
12.1.1 Global Allergy Immunotherapy Forecast by Region (2026-2031)
12.1.2 Global Allergy Immunotherapy Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Allergy Immunotherapy Forecast by Type (2026-2031)
12.7 Global Allergy Immunotherapy Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 ALK-Abello
13.1.1 ALK-Abello Company Information
13.1.2 ALK-Abello Allergy Immunotherapy Product Portfolios and Specifications
13.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ALK-Abello Main Business Overview
13.1.5 ALK-Abello Latest Developments
13.2 Stallergenes Greer
13.2.1 Stallergenes Greer Company Information
13.2.2 Stallergenes Greer Allergy Immunotherapy Product Portfolios and Specifications
13.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Stallergenes Greer Main Business Overview
13.2.5 Stallergenes Greer Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Allergy Immunotherapy Product Portfolios and Specifications
13.3.3 Merck Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Information
13.4.2 Allergy Therapeutics Allergy Immunotherapy Product Portfolios and Specifications
13.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Allergy Therapeutics Main Business Overview
13.4.5 Allergy Therapeutics Latest Developments
13.5 HAL
13.5.1 HAL Company Information
13.5.2 HAL Allergy Immunotherapy Product Portfolios and Specifications
13.5.3 HAL Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 HAL Main Business Overview
13.5.5 HAL Latest Developments
13.6 Holister Stier
13.6.1 Holister Stier Company Information
13.6.2 Holister Stier Allergy Immunotherapy Product Portfolios and Specifications
13.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Holister Stier Main Business Overview
13.6.5 Holister Stier Latest Developments
13.7 Leti
13.7.1 Leti Company Information
13.7.2 Leti Allergy Immunotherapy Product Portfolios and Specifications
13.7.3 Leti Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Leti Main Business Overview
13.7.5 Leti Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Allergy Immunotherapy Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Allergy Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subcutaneous Immunotherapy
Table 4. Major Players of Sublingual Immunotherapy
Table 5. Global Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 6. Global Allergy Immunotherapy Sales Market Share byType (2020-2025)
Table 7. Global Allergy Immunotherapy Revenue byType (2020-2025) & ($ million)
Table 8. Global Allergy Immunotherapy Revenue Market Share byType (2020-2025)
Table 9. Global Allergy Immunotherapy Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Allergy Immunotherapy Sale by Application (2020-2025) & (K Units)
Table 11. Global Allergy Immunotherapy Sale Market Share by Application (2020-2025)
Table 12. Global Allergy Immunotherapy Revenue by Application (2020-2025) & ($ million)
Table 13. Global Allergy Immunotherapy Revenue Market Share by Application (2020-2025)
Table 14. Global Allergy Immunotherapy Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Allergy Immunotherapy Sales by Company (2020-2025) & (K Units)
Table 16. Global Allergy Immunotherapy Sales Market Share by Company (2020-2025)
Table 17. Global Allergy Immunotherapy Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Allergy Immunotherapy Revenue Market Share by Company (2020-2025)
Table 19. Global Allergy Immunotherapy Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Allergy Immunotherapy Producing Area Distribution and Sales Area
Table 21. Players Allergy Immunotherapy Products Offered
Table 22. Allergy Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Allergy Immunotherapy Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Allergy Immunotherapy Sales Market Share Geographic Region (2020-2025)
Table 27. Global Allergy Immunotherapy Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Allergy Immunotherapy Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Allergy Immunotherapy Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Allergy Immunotherapy Sales Market Share by Country/Region (2020-2025)
Table 31. Global Allergy Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Allergy Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 34. Americas Allergy Immunotherapy Sales Market Share by Country (2020-2025)
Table 35. Americas Allergy Immunotherapy Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 37. Americas Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 38. APAC Allergy Immunotherapy Sales by Region (2020-2025) & (K Units)
Table 39. APAC Allergy Immunotherapy Sales Market Share by Region (2020-2025)
Table 40. APAC Allergy Immunotherapy Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 42. APAC Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 43. Europe Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 44. Europe Allergy Immunotherapy Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 46. Europe Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Allergy Immunotherapy Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Allergy Immunotherapy Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Allergy Immunotherapy Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Allergy Immunotherapy
Table 52. Key Market Challenges & Risks of Allergy Immunotherapy
Table 53. Key IndustryTrends of Allergy Immunotherapy
Table 54. Allergy Immunotherapy Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Allergy Immunotherapy Distributors List
Table 57. Allergy Immunotherapy Customer List
Table 58. Global Allergy Immunotherapy SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Allergy Immunotherapy RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Allergy Immunotherapy SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Allergy Immunotherapy Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Allergy Immunotherapy SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Allergy Immunotherapy Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Allergy Immunotherapy SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Allergy Immunotherapy RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Allergy Immunotherapy SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Allergy Immunotherapy RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Allergy Immunotherapy SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Allergy Immunotherapy RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Allergy Immunotherapy SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Allergy Immunotherapy RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ALK-Abello Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 73. ALK-Abello Allergy Immunotherapy Product Portfolios and Specifications
Table 74. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. ALK-Abello Main Business
Table 76. ALK-Abello Latest Developments
Table 77. Stallergenes Greer Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 78. Stallergenes Greer Allergy Immunotherapy Product Portfolios and Specifications
Table 79. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Stallergenes Greer Main Business
Table 81. Stallergenes Greer Latest Developments
Table 82. Merck Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Allergy Immunotherapy Product Portfolios and Specifications
Table 84. Merck Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. AllergyTherapeutics Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 88. AllergyTherapeutics Allergy Immunotherapy Product Portfolios and Specifications
Table 89. AllergyTherapeutics Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. AllergyTherapeutics Main Business
Table 91. AllergyTherapeutics Latest Developments
Table 92. HAL Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 93. HAL Allergy Immunotherapy Product Portfolios and Specifications
Table 94. HAL Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. HAL Main Business
Table 96. HAL Latest Developments
Table 97. Holister Stier Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Holister Stier Allergy Immunotherapy Product Portfolios and Specifications
Table 99. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Holister Stier Main Business
Table 101. Holister Stier Latest Developments
Table 102. Leti Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 103. Leti Allergy Immunotherapy Product Portfolios and Specifications
Table 104. Leti Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Leti Main Business
Table 106. Leti Latest Developments
LIST OFFIGURES
Figure 1. Picture of Allergy Immunotherapy
Figure 2. Allergy Immunotherapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Allergy Immunotherapy Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Allergy Immunotherapy Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Allergy Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Allergy Immunotherapy Sales Market Share by Country/Region (2024)
Figure 10. Allergy Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Subcutaneous Immunotherapy
Figure 12. Product Picture of Sublingual Immunotherapy
Figure 13. Global Allergy Immunotherapy Sales Market Share byType in 2025
Figure 14. Global Allergy Immunotherapy Revenue Market Share byType (2020-2025)
Figure 15. Allergy Immunotherapy Consumed in Allergic Rhinitis
Figure 16. Global Allergy Immunotherapy Market: Allergic Rhinitis (2020-2025) & (K Units)
Figure 17. Allergy Immunotherapy Consumed in Allergic Asthma
Figure 18. Global Allergy Immunotherapy Market: Allergic Asthma (2020-2025) & (K Units)
Figure 19. Allergy Immunotherapy Consumed in Others
Figure 20. Global Allergy Immunotherapy Market: Others (2020-2025) & (K Units)
Figure 21. Global Allergy Immunotherapy Sale Market Share by Application (2024)
Figure 22. Global Allergy Immunotherapy Revenue Market Share by Application in 2025
Figure 23. Allergy Immunotherapy Sales by Company in 2025 (K Units)
Figure 24. Global Allergy Immunotherapy Sales Market Share by Company in 2025
Figure 25. Allergy Immunotherapy Revenue by Company in 2025 ($ millions)
Figure 26. Global Allergy Immunotherapy Revenue Market Share by Company in 2025
Figure 27. Global Allergy Immunotherapy Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Allergy Immunotherapy Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 30. Americas Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 31. APAC Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 32. APAC Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 33. Europe Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 34. Europe Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Allergy Immunotherapy Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Allergy Immunotherapy Revenue 2020-2025 ($ millions)
Figure 37. Americas Allergy Immunotherapy Sales Market Share by Country in 2025
Figure 38. Americas Allergy Immunotherapy Revenue Market Share by Country (2020-2025)
Figure 39. Americas Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 40. Americas Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 41. United States Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Allergy Immunotherapy Sales Market Share by Region in 2025
Figure 46. APAC Allergy Immunotherapy Revenue Market Share by Region (2020-2025)
Figure 47. APAC Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 48. APAC Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 49. China Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 53. India Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Allergy Immunotherapy Sales Market Share by Country in 2025
Figure 57. Europe Allergy Immunotherapy Revenue Market Share by Country (2020-2025)
Figure 58. Europe Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 59. Europe Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 60. Germany Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 61.France Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Allergy Immunotherapy Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Allergy Immunotherapy Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Figure 68. Egypt Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Allergy Immunotherapy Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Allergy Immunotherapy in 2025
Figure 74. Manufacturing Process Analysis of Allergy Immunotherapy
Figure 75. Industry Chain Structure of Allergy Immunotherapy
Figure 76. Channels of Distribution
Figure 77. Global Allergy Immunotherapy Sales MarketForecast by Region (2026-2031)
Figure 78. Global Allergy Immunotherapy Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Allergy Immunotherapy Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Allergy Immunotherapy Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Allergy Immunotherapy Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Allergy Immunotherapy Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)
US$ 900.00
November 2016
85 pages
